Chai et al. [22] and Kang et al. [23] reported considerably high levels of plasma SESN2 in patients with obstructive sleep apnea and asthma, suggesting a compensatory response to chronic hypoxia. This evidence concerns the gene SESN2 and obstructive sleep apnea syndrome.